Child PTSD Symptom Scale
Child PTSD Symptom Scale (CPSS) is a psychological assessment tool primarily used to measure the severity of post-traumatic stress disorder (PTSD) symptoms in children aged 8-18 years. It was developed by Edna B. Foa, a renowned psychologist and PTSD researcher, and her colleagues in 2001. The CPSS is based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria for PTSD.
Overview[edit]
The CPSS is a 24-item self-report measure that assesses PTSD symptoms and their impact on a child's daily life. The scale is divided into three parts: the first part assesses the frequency of 17 PTSD symptoms, the second part assesses the severity of these symptoms, and the third part assesses the impairment caused by these symptoms in various areas of functioning.
Scoring[edit]
Each item on the CPSS is rated on a 4-point scale ranging from 0 (not at all) to 3 (5 or more times a week/very much). The total score ranges from 0 to 51, with higher scores indicating more severe PTSD symptoms. A score of 15 or above is considered indicative of a probable PTSD diagnosis.
Reliability and Validity[edit]
The CPSS has demonstrated good test-retest reliability and internal consistency, as well as good concurrent validity with other measures of PTSD in children. It has been used in various cultural contexts and has been translated into several languages.
Limitations[edit]
While the CPSS is a valuable tool for assessing PTSD symptoms in children, it is not a substitute for a comprehensive clinical assessment. It should be used in conjunction with other assessment tools and clinical judgment.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian